| Angela Monnig, | |
|
101 Manning Dr, Chapel Hill, NC 27514-4423 | |
| (919) 843-4810 | |
| Not Available |
| Full Name | Angela Monnig |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 22 Years |
| Location | 101 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033161542 | NPI | - | NPPES |
| 8052317 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 114836 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of North Carolina Hospital | Chapel hill, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians And Associates | 0648181156 | 1656 |
| Providence Anesthesiology Associates Pa | 3971566761 | 251 |
News Archive
Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.
E-cadherin is a molecule involved in adhesion between epithelial cells that also seems to have a protective role in cancer, since its loss is associated with tumour progression and metastases formation in a series of different cancers.
Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.
In a move that could have dire effects on health care in Idaho, the Senate State Affairs Committee voted yesterday to bring the Idaho Health Care Freedom Act (House Bill 391) one step closer to becoming law
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
› Verified 6 days ago
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.
E-cadherin is a molecule involved in adhesion between epithelial cells that also seems to have a protective role in cancer, since its loss is associated with tumour progression and metastases formation in a series of different cancers.
Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.
In a move that could have dire effects on health care in Idaho, the Senate State Affairs Committee voted yesterday to bring the Idaho Health Care Freedom Act (House Bill 391) one step closer to becoming law
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
› Verified 6 days ago
| Entity Name | Providence Anesthesiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396739884 PECOS PAC ID: 3971566761 Enrollment ID: O20041111000930 |
News Archive
Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.
E-cadherin is a molecule involved in adhesion between epithelial cells that also seems to have a protective role in cancer, since its loss is associated with tumour progression and metastases formation in a series of different cancers.
Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.
In a move that could have dire effects on health care in Idaho, the Senate State Affairs Committee voted yesterday to bring the Idaho Health Care Freedom Act (House Bill 391) one step closer to becoming law
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela Monnig, 143 W Franklin St, Chapel Hill, NC 27516-2539 Ph: (919) 843-4810 | Angela Monnig, 101 Manning Dr, Chapel Hill, NC 27514-4423 Ph: (919) 843-4810 |
News Archive
Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.
E-cadherin is a molecule involved in adhesion between epithelial cells that also seems to have a protective role in cancer, since its loss is associated with tumour progression and metastases formation in a series of different cancers.
Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.
In a move that could have dire effects on health care in Idaho, the Senate State Affairs Committee voted yesterday to bring the Idaho Health Care Freedom Act (House Bill 391) one step closer to becoming law
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
› Verified 6 days ago
Stephanie Nicole Brogdon, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: N2198 Unc Hospitals Cb# 7010, Chapel Hill, NC 27599 Phone: 919-966-5136 | |
Jorge Andres Orjuela, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: N2198 Unc Hospitals Clb # 70, Department Of Anesthesiology, Chapel Hill, NC 27599 Phone: 919-966-5136 Fax: 984-974-4873 | |
Mrs. Kristen Wolfinger Caraher I, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 209 Glen Haven Dr, Chapel Hill, NC 27516 Phone: 919-423-2566 Fax: 919-969-9895 | |
Monica A Belgado, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4996 Fax: 919-843-5515 | |
Tamara Meath, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 919-843-4810 | |
Terri Masier, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 919-843-4810 |